Lilly: Lilly Oncology Taking 'Aggressive' Position

The president of Lilly Oncology says the company has a "strong base" of existing and potential treatments to fuel a new strategy for its cancer-fighting pipeline. During a conference call with investors Tuesday morning, Sue Mahony said the company's oncology unit will be more aggressive in business development efforts, particularly when it comes to potential treatments in earlier stages "that clear a high bar."